Literature DB >> 18710356

Non-contraceptive benefits of oral contraceptives.

Johannes C Huber1, Eva-Katrin Bentz, Johannes Ott, Clemens B Tempfer.   

Abstract

BACKGROUND: There is increasing awareness of the opportunity that many contraceptive interventions may provide for additional health benefits. However, treatment of medical problems with oral contraceptives (OCs) is often an 'off-label' practice.
OBJECTIVE: The aim of this review is to summarize available data on non-contraceptive benefits of OCs.
METHODS: Review of the literature.
RESULTS: OCs have been shown to reduce the risk of ovarian, endometrial, and colorectal cancer. It has been suggested that OCs may be used in treatment of endometriosis, menorrhagia, and uterine leiomyomas. Pelvic inflammatory disease, dysmenorrhea, premenstrual syndrome, and acne have been shown to improve under OCs.
CONCLUSION: OCs are important for global and female health. Besides contraception, non-contraceptive effects of OCs are evidence based, well established, and commonly used in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710356     DOI: 10.1517/14656566.9.13.2317

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  4 in total

1.  Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey.

Authors:  David J Hooper
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

2.  Non-contraceptive benefits of oral hormonal contraceptives.

Authors:  Adolf E Schindler
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

3.  The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.

Authors:  Jimmy T Efird; Amanda E Toland; C Suzanne Lea; Christopher J Phillips
Journal:  Clin Med Insights Oncol       Date:  2011-03-27

4.  Novel effects of hormonal contraceptive use on the plasma proteome.

Authors:  Andrea R Josse; Bibiana Garcia-Bailo; Karina Fischer; Ahmed El-Sohemy
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.